Trial intelligence / Profile preview

Honghua Danpifen ointment for acute closed soft tissue injury

CTR20131770Phase 2Completed

Sponsor
Guangdong Zhongda Nanhai Marine Biotechnology Engineering
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of honghua danpifen in soft tissue injury, osteoarthritis (OA), sponsored by Guangdong Zhongda Nanhai Marine Biotechnology Engineering. Started Mar 2014; status: completed.

02

Drugs

honghua danpifen
03

Conditions

soft tissue injuryosteoarthritis (OA)

Beyond the preview

Go deeper on CTR20131770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call